Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

1 year ago

CHICAGO, IL / ACCESSWIRE / September 25, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified,…

Quantum BioPharma to Present at Global Growth and Investment Conference Presented by ArcStone Securities and Investments and Kingswood US

1 year ago

TORONTO, ON / ACCESSWIRE / September 25, 2024 / Quantum BioPharma Ltd. (formerly, FSD Pharma Inc.) (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma" or…

Berenson Acquisition Corp. I Announces Liquidation

1 year ago

New York, New York--(Newsfile Corp. - September 25, 2024) - Berenson Acquisition Corp. I, (NYSE American: BACA) a special purpose…

Red Light Holland’s Wholly Owned Subsidiary Happy Caps Partners with Trailbridge Mushroom Farms to Expand Mushroom Home Grow Kit Production in the USA

1 year ago

Toronto, Ontario--(Newsfile Corp. - September 25, 2024) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

INTASYL Technology and Compounds to be Focus of Presentation at 20th Annual Meeting of Oligonucleotide Therapeutics Society

1 year ago

--Data will be presented at the conference in October in MontrealMarlborough, Massachusetts--(Newsfile Corp. - September 25, 2024) - Phio Pharmaceuticals…

Sanner Group acquires Gilero to expand its global medical device offering

1 year ago

Sanner Group acquires Gilero to expand its global medical device offering Acquisition drives Sanner Group’s mission to offer a suite…

Incredable(TM) (Formerly Ready Doc(R)) Launches New Provider App and Announces Attendance at NAMMS Conference

1 year ago

As part of its recent rebrand, Incredable™ unveils a mobile app designed to streamline credentialing processes, reduce manual work, and…

Kronos Bio to Present Data at ACR Convergence 2024 to Support p300 KAT Inhibition as an Approach to Anti-Inflammatory Therapy

1 year ago

– Through selective inhibition of proinflammatory transcription, p300 KAT inhibition modulates the activity and function of multiple pro-inflammatory signaling pathways…

GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis

1 year ago

ANKARA, TURKEY / ACCESSWIRE / September 25, 2024 / GEN Pharmaceuticals (GENIL.IS), a leading Turkish pharmaceutical company, has announced the…